ARCHIVES

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Task Force Issues Guidless on LDCT Lung Screening

January 10, 2014

ODAC Recommends Iressa Approval As Third-Line Lung Cancer Treatment

September 27, 2002

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

Nine Saturation Program Planning Contracts Approved

May 9, 1975

Trials Approved by NCI CTEP For the Month of March

March 30, 2012